{"id":"autologous-cord-blood-mononuclear-cells","safety":{"commonSideEffects":[{"rate":"null","effect":"Graft-versus-host disease"},{"rate":"null","effect":"Infection"},{"rate":"null","effect":"Bleeding"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved by introducing cells that have the potential to differentiate into various cell types, which can then contribute to tissue repair and regeneration. The exact mechanisms of action are not fully understood, but it is thought that these cells may help to promote healing and reduce inflammation.","oneSentence":"Autologous cord blood mononuclear cells are used to stimulate the body's natural repair processes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:42:17.364Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of cerebral palsy"}]},"trialDetails":[{"nctId":"NCT03779711","phase":"PHASE2","title":"Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Timothy J Nelson, MD, PhD","startDate":"2019-06-06","conditions":"Hypoplastic Left Heart Syndrome","enrollment":95},{"nctId":"NCT04907526","phase":"PHASE1","title":"Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Timothy J Nelson, MD, PhD","startDate":"2021-06-01","conditions":"Congenital Heart Disease, SRV Dependent","enrollment":30},{"nctId":"NCT02881970","phase":"PHASE1, PHASE2","title":"Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells","status":"RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2020-02-05","conditions":"Neonatal Hypoxic-ischaemic Encephalopathy","enrollment":20},{"nctId":"NCT03526588","phase":"PHASE1","title":"Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH)","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-08-01","conditions":"Congenital Diaphragmatic Hernia","enrollment":3},{"nctId":"NCT01343394","phase":"PHASE1","title":"Safety of Autologous Human Umbilical Cord Blood Mononuclear Fraction to Treat Acquired Hearing Loss in Children","status":"WITHDRAWN","sponsor":"Aryn Knight","startDate":"2011-04","conditions":"Hearing Loss","enrollment":""},{"nctId":"NCT05087498","phase":"PHASE1","title":"Effect of Autologous Cord Blood-mononuclear Cells Infusion on Immune Microenvironment in Infants Born Very Preterm in NICU","status":"COMPLETED","sponsor":"Guangdong Women and Children Hospital","startDate":"2021-11-28","conditions":"Immunomodulation Effect","enrollment":8},{"nctId":"NCT04440670","phase":"PHASE3","title":"Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2020-06-20","conditions":"BPD","enrollment":140},{"nctId":"NCT01988584","phase":"PHASE2","title":"Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP).","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2013-11","conditions":"Cerebral Palsy","enrollment":20},{"nctId":"NCT01072370","phase":"PHASE1, PHASE2","title":"Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children","status":"WITHDRAWN","sponsor":"Augusta University","startDate":"2010-01","conditions":"Cerebral Palsy","enrollment":""},{"nctId":"NCT03431480","phase":"PHASE1","title":"Safety of Autologous Cord Blood Cells in HLHS Patients During Norwood Heart Surgery","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2018-02-16","conditions":"Hypoplastic Left Heart Syndrome, Heart Defects, Congenital, Pediatric Disorder","enrollment":10},{"nctId":"NCT01883076","phase":"PHASE1","title":"Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome","status":"COMPLETED","sponsor":"Timothy J Nelson, MD, PhD","startDate":"2013-05-15","conditions":"Hypoplastic Left Heart Syndrome","enrollment":30},{"nctId":"NCT05138276","phase":"EARLY_PHASE1","title":"Effect of Autologous Cord Blood Mononuclear Cells for Digestive System in Preterm Neonates","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2021-09-01","conditions":"Neonatal Necrotizing Enterocolitis, Growth and Development, Preterm Infants","enrollment":60},{"nctId":"NCT02999373","phase":"PHASE2","title":"Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates","status":"COMPLETED","sponsor":"Guangdong Women and Children Hospital","startDate":"2018-07-01","conditions":"Bronchopulmonary Dysplasia, Premature, Neonatal Death","enrollment":62},{"nctId":"NCT05071638","phase":"PHASE3","title":"Effect of Autologous Cord Blood Mononuclear Cells for Treatment of Bronchopulmonary Dysplasia in Extremely Preterm Neonates","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2021-10-01","conditions":"BPD","enrollment":76},{"nctId":"NCT04710810","phase":"PHASE1","title":"UCB Stem Cells for Autism Spectrum Disorders","status":"COMPLETED","sponsor":"St. Petersburg Bekhterev Research Psychoneurological Institute","startDate":"2019-11-04","conditions":"Autism Spectrum Disorder","enrollment":30},{"nctId":"NCT04768816","phase":"PHASE1","title":"Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2019-07-01","conditions":"Safety Issues;Effect of Drugs","enrollment":25},{"nctId":"NCT04501341","phase":"PHASE1, PHASE2","title":"BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2016-03-14","conditions":"T2D","enrollment":15},{"nctId":"NCT04311476","phase":"PHASE2","title":"Autologous Cord Blood Cells for Prevention of BPD in Preterm","status":"COMPLETED","sponsor":"yangjie","startDate":"2018-07-01","conditions":"Safety Issues, BPD - Bronchopulmonary Dysplasia, Neonatal Death","enrollment":62},{"nctId":"NCT03791372","phase":"PHASE1","title":"Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2017-10-10","conditions":"Safety Issues, Effect of Drugs","enrollment":25},{"nctId":"NCT03352310","phase":"PHASE1","title":"Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia","status":"UNKNOWN","sponsor":"Mononuclear Therapeutics Ltd.","startDate":"2018-04-16","conditions":"Hypoxic-Ischemic Encephalopathy, Hypoxia Neonatal, Cerebral Ischemia of Newborn","enrollment":40},{"nctId":"NCT02038972","phase":"PHASE1, PHASE2","title":"Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss","status":"COMPLETED","sponsor":"James Baumgartner, MD","startDate":"2013-01","conditions":"Sensorineural Hearing Loss","enrollment":11},{"nctId":"NCT03053076","phase":"PHASE1","title":"Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates","status":"UNKNOWN","sponsor":"Guangdong Women and Children Hospital","startDate":"2017-02-10","conditions":"Safety Issues, Effect of Drugs, Neonatal Death","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"autologous cord blood mononuclear cells","genericName":"autologous cord blood mononuclear cells","companyName":"Guangdong Women and Children Hospital","companyId":"guangdong-women-and-children-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"Autologous cord blood mononuclear cells are used to stimulate the body's natural repair processes. Used for Treatment of cerebral palsy.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}